The tumor microenviroment can secrete growth factors such as hepatocyte growth factor (HGF) which results in activation of the HGF receptor MET and subsequent downstream Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling which results in resistance to the small molecule inhibitors [73,74]. This evidence concerns the gene MAP2K7 and neoplasm.